Bluejay Diagnostics Enters Material Definitive Agreement

TL;DR

Bluejay Diagnostics signed a big deal on 7/23. Details to follow.

AI Summary

On July 23, 2025, Bluejay Diagnostics, Inc. entered into a material definitive agreement. The company, incorporated in Delaware with its principal executive offices in Acton, MA, filed this 8-K report on July 28, 2025, detailing the agreement.

Why It Matters

This filing indicates a significant new contract or partnership for Bluejay Diagnostics, which could impact its future operations and financial performance.

Risk Assessment

Risk Level: medium — Entering into a material definitive agreement is a significant event that could carry substantial implications, both positive and negative, for the company.

Key Numbers

• 001-41031 — Commission File Number (Identifies the company's SEC filing history.)
• 47-3552922 — I.R.S. Employer Identification No. (Tax identification number for the company.)

Key Players & Entities

• Bluejay Diagnostics, Inc. (company) — Registrant
• July 23, 2025 (date) — Date of earliest event reported
• July 28, 2025 (date) — Date of report
• Acton, MA (location) — Principal executive offices
• 001-41031 (company_id) — Commission File Number

FAQ

From the Filing

0001213900-25-068296.txt : 20250728 0001213900-25-068296.hdr.sgml : 20250728 20250728171018 ACCESSION NUMBER: 0001213900-25-068296 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20250723 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250728 DATE AS OF CHANGE: 20250728 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Bluejay Diagnostics, Inc. CENTRAL INDEX KEY: 0001704287 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 473552922 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41031 FILM NUMBER: 251156447 BUSINESS ADDRESS: STREET 1: 360 MASSACHUSETTS AVENUE, SUITE 203 CITY: ACTON STATE: MA ZIP: 01720 BUSINESS PHONE: (978) 631-0152 MAIL ADDRESS: STREET 1: 360 MASSACHUSETTS AVENUE, SUITE 203 CITY: ACTON STATE: MA ZIP: 01720 8-K 1 ea0250447-8k_bluejay.htm CURRENT REPORT false 0001704287 0001704287 2025-07-23 2025-07-23 iso4217:USD xbrli:shares iso4217:USD xbrli:shares     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549       FORM 8-K       CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934   Date of Report (Date of earliest event reported): July 23, 2025           BLUEJAY DIAGNOSTICS, INC. (Exact Name of Registrant as Specified in its Charter)       delaware   001-41031   47-3552922 (State or Other Jurisdiction of Incorporation or Organization)   (Commission File No.)   (I.R.S. Employer Identification No.)   360 Massachusetts Avenue , Suite 203 Acton , MA 01720 (Address of principal executive offices and zip code)   (844)   327-7078 (Registrant’s telephone number, including area code)     (Former name or former address, if changed from last report)       Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)     ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)     ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))     ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-14(c))   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company  ☒   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐             Item 1.01 Entry into a Material Definitive Agreement.   On July 23, 2025, Bluejay Diagnostics, Inc. (the “Company”) entered into an amendment (the “Amendment”) to its amended and restated license agreement (the “License Agreement”) and master supply agreement (the “Supply Agreement”) with Toray Industries, Inc. (“Toray”). The Amendment provides that the deadline under the License Agreement for the Company to establish an alternative manufacturing site for the Company’s Symphony cartridges has been extended from Octo